Skip to main content

Table 1 Demographic details from both study centres

From: Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients

Variable Centre 1 (n = 10) Centre 2 (n = 10)
Age (Years) 57.8 ± 15 58 ± 13.5
Male (%) 8 (80%) 7 (70%)
HR (bpm) 76 ± 14 68 ± 11.6
SBP (mmHg) 143 ± 33 143 ± 19
DBP (mmHg) 80. ± 15 72 ± 13
Dialysis Vintage (Months) 26 ± 26.2 9 ± 3.9
Past Medical and Drug History
HTN (n,%) 8 (80%) 6 (60%)
Diabetes (n,%) 3 (30%) 2 (20%)
Previous MI (n,%) 1 (10%) 2 (20%)
CAD (n,%) 3 (30%) 3 (30%)
PVD (n,%) 0 (0%) 1 (10%)
ACEi (n,%) 3 (30%) 1 (10%)
ARB (n%) 1 (10%) 0 (0%)
Diuretic (n,%) 1 (10%) 2 (20%)
Beta Blocker (n,%)* 4 (40%) 7 (70%)
Statin (n,%) 4 (40%) 5 (50%)
Calcium Channel Blocker (n,%) 3 (30%) 2 (20%)
Number of antihypertensives 0.96 ± 0.9 1.1 ± 0.9
  1. Mean values with standard deviation expressed as n ± SD. N, % = Chi-squared + %. No significant differences were observed between any baseline demographic details
  2. bpm beats per minute, ACEi angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, CAD coronary artery disease, DBP diastolic blood pressure, HR heart rate, HTN hypertension, MI myocardial infarction, PVD peripheral vascular disease, SBP systolic blood pressure
  3. *statistically significant difference between groups (P<0.05)